SCHEMBL4559539

SCHEMBL4559539

COc1cc2c(cc1OC)SC(CCO)(CCO)S2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
PPARG P37231 1/20 0.35
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
CA2 P00918 2/20 0.33
CA1 P00915 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
KDM4E B2RXH2 2/20 0.33
POLB P06746 1/20 0.33
ALOX15 P16050 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
CYP3A4 P08684 4/20 0.32
ALDH1A1 P00352 2/20 0.32
TSHR P16473 1/20 0.32
LDHA P00338 1/20 0.32
HTR2A P28223 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7133299 0.81
SCHEMBL4561971 0.70 CYP3A4 (0.39) PDE4APDE4BPDE4CPDE4DCA2
SCHEMBL1201869 0.64 CYP3A4 (0.46) PDE4APDE4BPDE4CPDE4DCA2
SCHEMBL29422790 0.64 CYP3A4 (0.46) PDE4APDE4BPDE4CPDE4DCA2
SCHEMBL4571012 0.64 CYP3A4 (0.46) PDE4APDE4BPDE4CPDE4DCA2
SCHEMBL7519367 0.62
SCHEMBL19014916 0.60 PDE4A (0.77) PDE4APDE4BPDE4CPDE4DCA2
SCHEMBL1276533 0.59 CYP3A4 (0.59) PDE4APDE4BPDE4CPDE4DCA2
SCHEMBL25143222 0.59 MTNR1A (0.45) PDE4APDE4BPDE4CPDE4DALOX15
SCHEMBL28383858 0.58 SNCA (0.53) PDE4APDE4BPDE4CPDE4DKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012062975-A1 NOVEL TRIARYLMETHYL RADICALS: PREPARATION AND USE THEREOF PHOSPHOENIX SARL (FR) 2012-05-18 WO disclosed
WO-2012062975-A1 NOVEL TRIARYLMETHYL RADICALS: PREPARATION AND USE THEREOF PHOSPHOENIX SARL (FR) 2012-05-18 WO disclosed